About Drug Delivery
There are 1.35K companies in the Drug Delivery sector across the world, with 757 funded companies having collectively raised $20.2B in venture capital money and private equity. Overall 328 of these are Series A+ funded and the sector has seen the creation of 2 Unicorns.
Drug Delivery sector has seen 76 acquisitions and 90 IPOs. This represents almost 12.3% of all such companies - which is higher than the 4.0% exit rate of tech companies in general.
This sector includes companies developing devices for the delivering of drugs or therapeutic agents to the human body.
Drug Delivery sector is also known as Pharmaceutical Drug Delivery, Targeted Drug Delivery System or Advanced Drug Delivery.
Companies included in Drug Delivery sector
Medical DevicesCompanies excluded in Drug Delivery sector
Biopharmaceuticals, Diagnostic Tests, Healthcare Service Providers, Digital Health Solutions (software, apps, online platforms)Market Map of Drug Delivery
The market map of Drug Delivery gives a visual overview of the sector, showing key business models, their interactions in the value chain, and industry evolution.
Reports related to Drug Delivery
Here are some reports related to Drug Delivery sector:
Free
Drug Delivery - Sector Report
Edition: September, 2026 (68 Pages)
Premium
Drug Delivery Investor Landscape
Edition: January, 2025
Premium
Drug Delivery Exit Landscape
Edition: August, 2026 (15 Pages)
View all reports related to Drug Delivery. Sign up today!Top Companies in Drug Delivery
There are more than 1.35K companies in Drug Delivery. Insulet is the top Drug Delivery company globally, ranked using Tracxn Score (what's this?).
Here are 5 of the top Drug Delivery companies globally:
Company | Description | Location | Founded | Current Stage | Private Funding Raised |
|---|---|---|---|---|---|
Manufacturer of wearable, tubeless insulin delivery systems for diabetes management | Boston (United States) | 2000 | Public | $120M | |
Developer of small-molecule drugs | Los Angeles (United States) | 1991 | Public | $50M | |
Provider of platform to deliver mRNA therapeutics for multi functional treatments | Cambridge (United States) | 2017 | Series B | $256M | |
Developer of therapeutics for pulmonary hypertension and cardiopulmonary conditions | Morrisville (United States) | 2004 | Public | $90.3M | |
Developer of drug delivery technologies for the treatment of various diseases | San Diego (United States) | 1999 | Public | - |
Companies founded year-on-year in the Drug Delivery sector
25 new startups have been founded so far in 2026 in the Drug Delivery sector. 73 Drug Delivery startups were founded in 2017 - this is the most number of startups founded in any year in the last 10 years.
- Total Number of Companies
Year | No. of companies |
|---|---|
2026 | 25 |
2025 | 30 |
2024 | 22 |
2023 | 20 |
2022 | 39 |
2021 | 49 |
2020 | 62 |
2019 | 71 |
2018 | 61 |
2017 | 73 |
Companies founded across countries in the Drug Delivery sector
United States has 636 Drug Delivery startups, the most by any country, followed by United Kingdom which has 103 startups and Canada which has 58.
- Total Number of Companies
Country | No. of companies |
|---|---|
United States | 636 |
United Kingdom | 103 |
Canada | 58 |
Israel | 52 |
Germany | 44 |
China | 41 |
India | 41 |
South Korea | 41 |
Switzerland | 31 |
Sweden | 27 |
Stage-wise distribution of the Drug Delivery sector
Out of the total 1,346 Drug Delivery companies, 757 have secured funding. Among them, 328 have reached Series A or higher, and 245 to Series B or beyond.
Founded - 1,346
Funded - 757
Series A+ - 328
Series B+ - 245
Series C+ - 189
Company Stage | No. of companies |
|---|---|
Founded | 1,346 |
Funded | 757 |
Series A+ | 328 |
Series B+ | 245 |
Series C+ | 189 |
Want to know more about Drug Delivery ? Signup and explore Tracxn for free
- 1.4K+ Total Companies
- $20.2B+ Total Funding
- 755+ Funded Companies
- 85+ IPOs
- 75+ Acquisitions
- 5+ Reports
Funding Trends in the Drug Delivery sector
Total funding year-on-year in the Drug Delivery sector
The Drug Delivery sector saw a total funding of more than $12.9B in the last 10 years. The most amount of funding was in 2021 at more than $3.05B. There has been a total funding of $514M in 2026 till date.
- Total Funding
Year | Total Funding |
|---|---|
2026 | $514M |
2025 | $1.23B |
2024 | $639M |
2023 | $1.06B |
2022 | $1.87B |
2021 | $3.05B |
2020 | $1.25B |
2019 | $1.09B |
2018 | $968M |
2017 | $1.17B |
Total funding across countries in the Drug Delivery sector
In the last 10 years, Drug Delivery startups in United States have recieved the highest funding among all countries - $7.69B. China follows with $1.81B and Switzerland with $347M.
- Total Funding
Country | Total Funding |
|---|---|
United States | $7.69B |
China | $1.81B |
Switzerland | $347M |
United Kingdom | $269M |
Israel | $199M |
France | $136M |
Canada | $114M |
Japan | $63.6M |
Netherlands | $34.8M |
Sweden | $24M |
Total funding amount raised by stage in the Drug Delivery sector
Over the last 10 years, the Drug Delivery sector have seen $343M into Seed Stage funding rounds, $4.03B into Early Stage funding rounds and $3.6B go into Late Stage funding rounds.
Funding Stage | Total Funding |
|---|---|
Early Stage | $4.03B |
Late Stage | $3.6B |
Post IPO | $2.67B |
Debt | $681M |
Grant | $509M |
Seed Stage | $343M |
Other-Equity | $763K |
Recent Funding Rounds in Drug Delivery
In the year 2026, till September 2026, Drug Delivery companies have raised $491M in equity funding across 32 rounds.
In the same period last year (i.e. till September 2025), Drug Delivery companies had raised $825M across 40 rounds.
So, 2026 has seen a 40.45% drop in funding in Drug Delivery companies as compared to 2025.
Here are some recent, important funding rounds in Drug Delivery:
Company | Round Raised | Amount Raised | Funding Date | Investors |
|---|---|---|---|---|
Series A | 4584 | Sep 29, 2026 | ||
Series A | 7383 | Sep 17, 2026 | ||
Series A | 3060 | Sep 09, 2026 | ||
Seed | 5944 | Sep 02, 2026 | ||
Series A | 8302 | Sep 01, 2026 |
Top Investors in Drug Delivery
HHS is the top investor in Drug Delivery companies based on number of companies invested.
Here are some top investors in Drug Delivery:
Investor | Location | Top Portfolio Companies |
|---|---|---|
Washington, DC (United States) | ||
Arlington (United States) | ||
Seattle (United States) | ||
M&A activity in Drug Delivery
In the year 2026, till September 2026, 4 acquisitions happened in Drug Delivery sector. Last year, in 2025, a total of 9 acquisitions happened in Drug Delivery sector.
Here are some recent, important acquisitions in Drug Delivery:
Company | Acquisition Type | Acquisition Date | Acquirers |
|---|---|---|---|
Business Acquisition | Sep 10, 2026 | ||
Business Acquisition | Jul 16, 2026 | ||
Business Acquisition | Jun 01, 2026 | ||
Business Acquisition | Mar 22, 2026 | ||
Business Acquisition | Dec 23, 2025 |
Acquisition trends in Drug Delivery
Here are the acquisition trends in Drug Delivery:
- Total Number of Acquisitions
Year | No. of companies |
|---|---|
2026 | 4 |
2025 | 9 |
2024 | 1 |
2023 | 5 |
2022 | 3 |
2021 | 7 |
2020 | 4 |
2019 | 3 |
2018 | 5 |
2017 | 8 |
IPOs in Drug Delivery
In the year 2026, till May 2026, 2 IPOs happened in Drug Delivery sector.
Here are some recent, important IPOs in Drug Delivery:
Company | IPO Date | Exchange Symbol |
|---|---|---|
May 13, 2026 | Hong Kong Exchanges (HKG) | |
Feb 02, 2026 | Taiwan Stock Exchange (TPE) | |
Dec 12, 2025 | Korea Exchange (KRX) | |
Dec 04, 2025 | New York Stock Exchange (NYSEMKT) | |
Aug 14, 2025 | Korea Exchange (KRX) |
_1576144454885.png?devicePixelRatio=2&height=20&width=20){kind=logo}
Colleges which produce the most Drug Delivery companies
Companies founded by alumni from top colleges in the Drug Delivery sector
Most number of Drug Delivery startups have been founded by alumni from Massachusetts Institute of Technology, University of Cambridge and Harvard University.
College | No. of companies |
|---|---|
Massachusetts Institute of Technology | 22 |
University of Cambridge | 11 |
Harvard University | 9 |
Stanford University | 9 |
University of California (Berkeley) | 9 |
Cornell University | 8 |
University of Pennsylvania | 8 |
Columbia University | 7 |
University of Oxford | 5 |
Yale University | 5 |
Total funding in companies founded by alumni from top colleges in the the Drug Delivery sector
In the last 10 years, Massachusetts Institute of Technology graduates' Drug Delivery companies have raised the most funding among top colleges. Yale University alumni are second, and University of Cambridge alumni are third.
College | Total Funding |
|---|---|
Massachusetts Institute of Technology | $891M |
Yale University | $408M |
University of Cambridge | $406M |
Columbia University | $383M |
Carnegie Mellon University | $371M |
University of California (Berkeley) | $360M |
Stanford University | $334M |
Harvard University | $208M |
Duke University | $177M |
Cornell University | $167M |
Top News in Drug Delivery
•
OnDosis and Adare Partner on ADHD Drug Development CollaborationContract Pharma•Sep 30, 2026•Adare Pharma Solutions, OnDosis
•
•
Handa Receives FDA Approval for OMCAZIO™ (cabozantinib)Access Newswire•Sep 15, 2026•Handa Biotech Pharmaceutical
•
Beyond Air Receives FDA Breakthrough Device Designation for LungFit GO for NTM-PD TreatmentGlobeNewswire•Aug 31, 2026•Beyond Air
•
Cellectar Biosciences GAAP EPS of -$0.57 misses by $0.05 (CLRB:NASDAQ)Seeking Alpha•Aug 13, 2026•Cellectar Biosciences
•
•
•
•
Cellectar Myeloma Data: 84.6% of 26 Evaluable Patients Stable or BetterStocktitan•Jul 15, 2026•Cellectar Biosciences
•
Enable Injections' On-Body Injector Wins FDA Nod for Sanofi Anticancer DrugMedical Product Outsourcing•Jul 13, 2026•Enable Injections
